HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
about
Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variantsInteraction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancerGenetic susceptibility to HPV infection and cervical cancer.Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model.Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.Human papillomavirus and cervical cancer.Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.Genome variation of human papillomavirus types: phylogenetic and medical implications.Epidemiological and functional implications of molecular variants of human papillomavirus.Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.HPV16 genetic variation and the development of cervical cancer worldwide.HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patientsTherapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen.Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British womenImmune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer.HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan.Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma.Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.HLA class II alleles associated with infection by HPV16 in cervical cancer in situ.Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology.Human papillomavirus type-16 variants in Quechua aboriginals from Argentina.High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18.Human papillomavirus genome variants and head and neck cancers: a perspective.Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans
P2860
Q28481495-46C320B1-4272-4AE6-9C65-FED36E2F30C0Q33362569-92245D21-41BE-4026-8E5D-7801ABA7EC01Q33716371-41B04D6D-3BE7-4247-8037-12FB222D05A1Q33874465-4BA1C996-EB17-45C4-8A05-5595509DC2D0Q34147515-72D2499A-748F-4C69-8163-7A52127D1A96Q34209101-C3DF5CC3-F943-497F-8E52-19602CD4D438Q34580052-D96C09C1-AE30-4751-9878-01A14C2324E4Q35129010-CAADB2EE-FFE3-44F7-B633-71383405F012Q35139997-9B334B3B-C2FE-4517-BCA9-DBC55EED6A71Q36280182-7BDF44EF-AD4D-43D4-9C68-D5B16D8C2867Q36301217-39FA741D-DFFE-450A-9C41-6C8382B552FBQ36332540-D44A1032-7DDF-4776-880B-19829A2F9D69Q36496764-C269ED18-2C4A-4D29-AF4D-7CD89BAB3D66Q36497960-F7064882-5ED3-4A66-B14F-EEA131B09870Q36557809-FD732673-0C00-4F8C-87BC-7B5BA4B9D0A7Q36622790-C2B8CD39-AD3C-41AE-B7FC-AA845E3DC083Q36623092-151B4F2A-CE8A-4D31-BBBA-BE36765658DDQ36641670-F2A89340-62BB-4210-9C71-284007F282E9Q36794745-F71EC51E-8A7B-4316-B8D5-A0BCF30CDC9CQ36974722-EEDD0557-318B-48EC-8C18-E95CA37B6C60Q37227774-3073BE9B-09D7-4956-AD37-B4B4B83BAE8FQ37448947-88A3BFC9-6BFB-411B-A3D2-0339BE2FE13CQ40779960-3AD365F4-9DFE-4263-87D7-2AA7E198ED75Q42232821-ABD9711A-BA59-41F0-9FB6-7B867293E980Q42283899-7656C2F3-137C-4097-A3A5-CE0D044288C4Q42604851-380A92C1-CACF-452B-A3D0-F5D8561962E4Q42662200-ADEE3722-7C27-4B47-B37F-88F5EAC8510AQ42693441-62E21AF2-B25A-4CB7-B2EB-CBAD856CEA24Q43662401-0AF67145-5EDF-4AEB-BBF1-47143D206950Q46449495-9CC39002-8C41-4E07-89F3-144D0A9F2E79Q48258370-172B0B84-F1D2-431A-8189-B9730CDC2EDAQ54561703-76E286A2-7D15-4E98-B913-315945202384Q55284319-4346C115-F533-469D-860A-FD5AF53D1E40Q58085168-705CD832-0175-4641-9C4F-440E2AE643A0
P2860
HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
HPV 16 infection and progressi ...... d HPV 16 E6 sequence variants.
@en
HPV 16 infection and progressi ...... d HPV 16 E6 sequence variants.
@nl
type
label
HPV 16 infection and progressi ...... d HPV 16 E6 sequence variants.
@en
HPV 16 infection and progressi ...... d HPV 16 E6 sequence variants.
@nl
prefLabel
HPV 16 infection and progressi ...... d HPV 16 E6 sequence variants.
@en
HPV 16 infection and progressi ...... d HPV 16 E6 sequence variants.
@nl
P2093
P2860
P1476
HPV 16 infection and progressi ...... nd HPV 16 E6 sequence variants
@en
P2093
C J Meijer
H J Bontkes
J M Walboomers
M F Duggan-Keen
M J Stukart
M van Duin
R H Verheijen
R J Scheper
P2860
P304
P356
10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-X
P577
1998-10-01T00:00:00Z